Apogee Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Apogee Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2022 to Q4 2023.
  • Apogee Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending December 31, 2023 was 10M shares.
Preferred Stock, Shares Authorized, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 10M +10M Dec 31, 2023 10-K 2024-03-05
Q3 2023 10M Sep 30, 2023 10-Q 2023-11-13
Q4 2022 0 Dec 31, 2022 10-K 2024-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.